MedPath

To test the safety and benefits of the hydration mist on all type skin.

Not Applicable
Completed
Registration Number
CTRI/2023/05/052949
Lead Sponsor
DPKA Universal Consumer Ventures Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

• Healthy female subjects of 18 to 50 years age. Include subjects with all skin types

• Non-pregnant/non-lactating females.

• Subject who had normal Fitzpatrick skin type III to V.

Exclusion Criteria

• Subjects who are pregnant, breast feeding or planning a pregnancy

• Subjects who have demonstrated a previous hypersensitivity reaction to any of the ingredients of the

study products.

• Medication which may affect skin response and/or past medical history as determined by the

investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Hydration of bare face by Derma Lab Combo before treatment of hydrating mist (0 min), 30 mins and 4hrs after treatment will be evaluated. <br/ ><br>2. 30 mins post application of make up or when considered set by the make-up artist spray the hydrating mist as directed & fill the response form the subjects <br/ ><br>3. Digital images of the bare face and make up are taken before the treatment with hydrating mist (0 min) and 30 mins after treatment with hydrating mist. <br/ ><br>4. Clinical efficacy graded by Griffiths scale is scored before the application of hydrating mist (0 min), 30 min and 4 hr. after application of the hydrating mist on bare face.Timepoint: Day 1 <br/ ><br>Bare Face: 0 min, 30 min, 04 Hours <br/ ><br>Make up Face: 0 min, 30 min <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ot ApplicableTimepoint: Not Applicable
© Copyright 2025. All Rights Reserved by MedPath